Document is current
Any future updates will be listed below
-
Authors
Djukovic, Ana https://orcid.org/0000-0001-8068-7188
Garzón, María José https://orcid.org/0000-0002-9136-1236
Canlet, Cécile
Cabral, Vitor
Lalaoui, Rym
García-Garcerá, Marc https://orcid.org/0000-0001-6408-7561
Rechenberger, Julia https://orcid.org/0000-0003-4189-3434
Tremblay-Franco, Marie
Peñaranda, Iván
Puchades-Carrasco, Leonor https://orcid.org/0000-0003-0340-7458
Pineda-Lucena, Antonio
González-Barberá, Eva María
Salavert, Miguel
López-Hontangas, José Luis
Sanz, Miguel Á. https://orcid.org/0000-0003-1489-1177
Sanz, Jaime
Kuster, Bernhard https://orcid.org/0000-0002-9094-1677
Rolain, Jean-Marc
Debrauwer, Laurent
Xavier, Karina B. https://orcid.org/0000-0001-5210-1434
Xavier, Joao B. https://orcid.org/0000-0003-3592-1689
Ubeda, Carles https://orcid.org/0000-0003-0560-4658
- License Information
-
More Information
Article History
Received: 11 August 2021
Accepted: 9 September 2022
First Online: 24 September 2022
Competing interests
: M.S. has participated as a consultant in advisories and scientific meetings organized or sponsored by the companies GSK, Gilead, MSD, Pfizer, and Shionogi in the last two years, having given lectures for some of them. There is no direct overlap between the current study and these consulting duties. C.U. has participated as a consultant of Vedanta Biosciences and The Zambon Group. There is no direct overlap between the current study and these consulting duties. The rest of the authors do not have competing interest.
